Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.335\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1ccc(S(=O)(=O)NC(C(=O)OCC(=O)NC(=O)c2cccn2C)C(C)C)cc1
b: CCC(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
c: O=C1C=C(c2cc3ccccc3s2)C[C@@H](c2ccc(F)cc2)C1
Answer: b. CCC(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
CCC(Cc1ccccc1)n1c(=S)[nH]c2ccccc2c1=O
3-(1-phenylbutan-2-yl)-2-sulfanylidene-1H-quinazolin-4-one